To further confirm the underlying mechanism by which BAF312 inhibits tumor growth and antivascular formation, we conducted immunohistochemical analysis, and the results indicated that S1PR1, P-STAT3, and VEGFA were downregulated. The gene discussed is STAT3; the disease is neoplasm.